Welcome to jimtrade
Sign In | Join Free
 
in
Home > Trade News > Biocon introduces BASALOG
Biocon introduces BASALOG
 
Biocon introduces BASALOG
Biocon Ltd has launched BASALOG, a long acting (24 hours) peak less human insulin analogue, Glargine. The product is available in India in 10 ml and 3 ml vials.

Kiran Mazumdar Shaw, Chairman and Managing Director, Biocon stated, "Diabetes is a debilitating disease that is pervading global populations like a pandemic with India at its epicenter. Biocon is a committed to developing affordable Insulin based therapies to manage this disease burden."

Posted On : 5/30/2009 10:47:56 AM

 
 
 
Biocon introduces BASALOG